A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03596645 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03596645
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2023-11-21
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.